Similar Papers

Paper Title
Journal
Date
Author
Immune response to three doses of mRNA SARS-CoV-2 vaccines in CD19-targeted chimeric antigen receptor Tcell immunotherapy recipients.
Pierre Sesques ... Florence Ader
Cancer cell | VOL. 40
Pierre Sesques, et. al.Pierre Sesques ... Florence Ader
25 Jan 2022
Oncology Treatment in the Era of COVID-19: We Cannot Afford to Hit the Pause Button.
Sarah A Holstein ... Julie M Vose
Clinical Pharmacology & Therapeutics | VOL. 108
Sarah A Holstein, et. al.Sarah A Holstein ... Julie M Vose
27 Jun 2020
Vaccinations following CAR-T cell therapy: summary of reported cases and state-of-the-art review of current recommendations
Jan Styczyński ... Magdalena Woźniak
Acta Haematologica Polonica | VOL. 53
Jan Styczyński, et. al.Jan Styczyński ... Magdalena Woźniak
30 Jun 2022
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
Jia Wei ... Meifang Han
Journal for ImmunoTherapy of Cancer | VOL. 8
Jia Wei, et. al.Jia Wei ... Meifang Han
01 Jul 2020
View more papers

More From: Advanced Therapeutics

Paper Title
Journal
Date
Author
Recent Advances in Promoting Bone Regeneration in Type 2 Diabetes Using Drug Delivery Vehicles and Vehicle‐Free Therapeutics
Yasamin Pesaran Afsharian ... Hermann Seitz
Advanced Therapeutics | VOL. -
Yasamin Pesaran Afsharian, et. al.Yasamin Pesaran Afsharian ... Hermann Seitz
12 Jan 2025
Therapeutic Effect of a Near‐Infrared Responsive MTX‐Mn3O4@PDA Nano‐Delivery System on Rheumatoid Arthritis
Xinwei Zhang ... Mingming Chang
Advanced Therapeutics | VOL. -
Xinwei Zhang, et. al.Xinwei Zhang ... Mingming Chang
12 Jan 2025
Role of the Extracellular Matrix in Cancer: Insights into Tumor Progression and Therapy
Nimeet Desai ... Lalitkumar K Vora
Advanced Therapeutics | VOL. -
Nimeet Desai, et. al.Nimeet Desai ... Lalitkumar K Vora
06 Jan 2025
Issue Information (Adv. Therap. 1/2025)
-
Advanced Therapeutics | VOL. 8
--
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.